Safety Of Anti-NGFs For Osteoarthritis Pain To Be Weighed By Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
The entire class of biologics has fallen under suspicion of worsening the very condition it is supposed to treat, and FDA has imposed clinical holds on ongoing trials.